SUMMARY Ten cases are reported of short incubation (one to four weeks) non-A, non-B hepatitis occurring after infusion of various preparations of factor VIII concentrates into patients with coagulation disorders. Five patients were symptomatic and, in all, serum transaminase levels were increased for at least six months. These cases of chronic hepatitis exhibited none of the features of autoimmune chronic hepatitis: autoantibodies were negative and serum immunoglobulins were normal. Hepatic histology confirmed acute hepatitis in two cases biopsied early in the illness, and thronic active hepatitis (three) or chronic persistent hepatitis (two) in five cases studied later. Lobular inflammation was a prominent feature in all cases. Other features not commonly associated with type A or B hepatitis included fatty change and damaged bile ducts.
Patients with congenital coagulation disorders receive large quantities of blood derivatives and acute hepatitis is not an uncommon occurrence. The development of serological techniques to identify acute type A and B hepatitis has led to the conclusion that additional hepatitis viruses exist.' 2 These have been provisionally designated the non-A, non-B hepatitis viruses.
There is evidence of more than one type of non-A, non-B virus. A drug addict suffered four attacks of hepatitis, one proven type A, another type B, and, in addition, two other episodes.' Chimpanzees, after factor IX injections, have developed non-A, non-B hepatitis with an incubation period of 10 weeks, to be followed by hepatitis 10 to 14 days after infusion of factor VIII.45 In chimpanzees, electron microscopy has shown two cytologically distinct non-A, non-B hepatitises, one with cytoplasmic and the other with nuclear changes.6 7 The antigen characteristics of these non-A, non-B viruses have not been adequately elucidated. Shirachi et al.8 described an antigen/anti-*Dr Arborgh died before this paper was published.
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Results

CLINICAL FEATURES
Acute hepati'tis was seen after infusion of cryoprecipitate, commercial and NHS factor VIII concentrates. In the five patients receiving a single infusion in the three months before the hepati'tis, the incubation period (itime from infusion to first documented abnormal transaminase) was from one to four weeks. In the remaining five cases the infusate responsible for transmission of the infection could not be established with certainty, although the interval between the last infusion and the onset of raised transaminase was also one to four weeks.
Five patients had symptoms (Table 2) . They complained of lethargy, nausea (rarely vomiting), abdominal discomfort, and icterus. In one patient these symptoms were severe and persistent and eventually, seven months after the onset, necessitated steroid therapy.
Six or more months after the beginning of the illness, four patients had mild splenomegaly but oesophageal varices could not be demonstrated radiologically.
L I V ER FUNCTI ON TESTS
The rise in peak transaminase was usually within the first month, ranging from 139-1095 IU/1 (normal <15 IU/1). The transaminase levels then fluctuated rapidly, changing from levels higher than 300 IU/1 to normal levels over a period of one to two weeks (Fig. 1) . Although the general trend was towards a reduction of peak levels during the course of the disease, all patients still had abnormal levels at six or more months. The pattern of transaminase abnormality was similar in patients receiving single and multiple infusions of concentrate. There was no change in titre of antibody to Epstein-Barr vir4s, cytomegalovirus, herpes simplex, measles, and rubella between acute and later sera.
HISTOLOGY
Light microscopy (Table 3) The acute hepatitis in patient 1 (Fig. 2) was histologically mild, and characterised by centrilobular liver-cell swelling, fatty change, and both canalicular and intracellular cholestasis. Swollen cells had unusually large nucleoli. A few acidophilic bodies and liver-cell mitoses were seen. Kupffer cells were enlarged and PAS-positive, and some stained for iron. The mixed inflammatory infiltrate, composed of lymphocytes, plasma cells, and segmented leucocytes was sparse. There was no bridging necrosis. An operative liver biopsy taken at laparotomy three months earlier had shown a few inflammatory cells in portal tracts and sinusoids, but no evidence of liver-cell damage.
Both biopsies taken at three to six months (patients 6 and 7) showed, in addition to focal liver-cell damage and focal thickening of liver-cell plates, a heavy infiltration by mononuclear cells. In the biopsy of patient 6 the abundant portal r-a..,.X X*,;J In contrast with these two biopsies, the specimen from patient 3, taken seven* months after onset, showed the balance between liver-cell damage and inflammatory infiltrate more usually associated with viral hepatitis. In the two later biopsies of patients 8 and 10 inflammatory infiltration was again unusually severe (Fig. 3) .
Bile duct damage was noted in patients 4, 6, and 8 and corresponded to the lesion described by Poulsen and Christofferson13 in that only a segment of bile duct wall was involved, and affected cells we're vacuolated and stratified (Fig. 4) .
Immunofluorescence
The biopsies were negative for HBc and HBs antigen. 
Discussion
This report describes a group of patients who developed non-A, non-B hepatitis after infusion with factor VIII concentrate or cryoprecipitate. In five of these patients the disease was asymptomatic and anicteric, but in 'five it was more severe, being associated with nausea, vomiting, and icterus.
Because some patients had received multiple infusions, the identification of the infectious infusate was impossible and incubation period could not be defined. However, in five cases, a single infusion had been administered in the 13 weeks before the development of raised ;transaminases, and in these cases the incubation period was one to four weeks. This incubation period is similar to that noted in previous reported episodes of non-A, non-B hepatitis in haemophiliac patients14 15 and chimpanzees5 receiving factor VIII concentrates. In five of our cases several infusions had been administered in the three months before the iI t it vk 9 onset of the hepatitis, bult 'the interval between the last infusion and the onset of hepatitis was one to four weeks. Because of the similarity of this interval to the established incubation period in the other patients, it seems possible that the last infusion was indeed responsible for transmission of the infectious agent.
Although clinically similar to a previously reported episode of short incubation hepatitis in haemophiliac patients,'5 16 none of our patients recovered within six months, whereas all those previously reported had done so within a few months. Although this difference may merely be a reflection of small sample size, it may indicate the presence of more than one type of short incubation non-A, non-B hepatitis virus, only one of which has a high rate of induction of chronic liver disease. Another factor relating to chronicity may be repeated infusion of infected material after the onset of hepatitis. This seems unlikely in that three patients who received a single infusion manifested the same clinical and biochemical course as those who received multiple infusions.
The failure of these patients to recover within the period of study (six to 45 months) suggests that this viral agent is an important cause of chronic liver disease in patients with coagulation disorders and possibly also in the general population. Autoantibody formation and raised globulin levels were not seen, so that this type is serologically similar to chronic active liver disease induced by hepatitis B virus but dissimilar to autoimmune chronic active hepatitis.
Liver histology in three patients showed mild or moderate chronic active hepatitis and in two chronic persistent hepatitis. A prominent feature was the intense lobular sinusoidal mononuclear cell infiltration which had previously been noted in chimpanzees with this infection,'4 and is reminiscent of infectious mononucleosis or cytomegalovirus infection. Other features not commonly associated with viral hepatitis included fatty change (patients 1, 4, and 10), a small granuloma (patient 6), and damaged bile ducts (patients 4, 6, and 8). The long-term significance of the chronic changes that were observed cannot be assessed on histological grounds, as there is no precedent on which to base prognostic judgements. Follow-up, both clinical and histological, will be needed to establish the natural history of this disease. 
